• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude Medical pushes ‘play’ on Portico TAVI device

St. Jude Medical pushes ‘play’ on Portico TAVI device

March 12, 2015 By Brad Perriello

St. Jude Medical hits 'play' on Portico TAVI device

St. Jude Medical (NYSE:STJ), which paused implantations of its Portico replacement heart valve last fall out of an abundance of caution, told MassDevice.com today that European authorities reinstated Portico’s CE Mark.

The decision means St. Jude is resuming clinical and commercial implants of the Portico 23mm and 25mm transcatheter aortic valve implants in Europe, spokesman Justin Paquette told us via email.

"We remain in discussions with the FDA to gain approval to resume implants in our U.S. [investigational device exemption trial]," Paquette wrote.

Back in September 2014, St. Jude said CT scans turned up a potential problem with the valves in "a small number of cases," in which "reduced valve mobility" was seen in patients after 4D CT scans at 30 days.

But internal and external reviews of the valve "found no excess rate of clinical events associated with either Portico or control valves exhibiting the leaflet motion observation and patients with this leaflet motion observation were found to be asymptomatic," Paquette told us.

At the time there was speculation that the observation was due to "motion artifact" created by the imaging scan.

Paquette told us that St. Jude performed an "extensive review" of leaflet motion using CT scans and trans-esophageal echocardiography. The leaflet motion "was determined to be caused by the presence of a subclinical layer of thrombus," he wrote.

"The majority of patients analyzed had normal leaflet motion and patients with this leaflet motion observation were found to be asymptomatic," Paquette wrote.

STJ shares closed up 0.9% at $67.07 apiece today.

Filed Under: News Well, Regulatory/Compliance, Replacement Heart Valves Tagged With: CE Mark, Clinical Trials, stjudemedical

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy